Chevy Chase Trust’s Immunomedics Inc IMMU Stock Holding History

Chevy Chase Trust’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,900	Closed	-$40K	–	1120
2019 Q4	$40K	Buy	+1,900	New	+$33.5K	﹤0.01%	871

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chevy Chase Trust's IMMU Position: Q1 2020 in Review

Chevy Chase Trust sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 1,900 shares — an estimated $40K sold.

Chevy Chase Trust first reported a position in IMMU in Q4 2019 and held it in 1 quarter. The position peaked at $40K in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

Chevy Chase Trust reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
Chevy Chase Trust sold 1,900 Immunomedics Inc shares in Q1 2020, an estimated $40K.
Chevy Chase Trust first reported a position in Immunomedics Inc in Q4 2019 and held it in 1 quarter.
Chevy Chase Trust's Immunomedics Inc position peaked at $40K in Q4 2019.
220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Chevy Chase Trust's 13F filing for Q1 2020, filed 13 May 2020.